Marginalizing the Genomic Architecture to Identify Crosstalk Across Cancer and Neurodegeneration

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2023 Mar 16

PMID 36923654

Authors

Amit Sharma

Ullrich Wullner

Ingo G H Schmidt-Wolf

Jarek Maciaczyk

Affiliations

Soon will be listed here.

Citing Articles

Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies.

Wang Y, Qin J, Sharma A, Dakal T, Wang J, Pan T Cancer Cell Int. 2024; 24(1):305.

PMID: 39227952 PMC: 11373255. DOI: 10.1186/s12935-024-03487-y.

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment.

Pu J, Liu T, Sharma A, Schmidt-Wolf I BMC Med Genomics. 2023; 16(1):295.

PMID: 37978516 PMC: 10657130. DOI: 10.1186/s12920-023-01724-3.

Insights on ZEB1-AS1: emerging roles from cancer to neurodegeneration.

Carelli S, Rey F, Maghraby E, Cereda C Neural Regen Res. 2023; 19(6):1187-1188.

PMID: 37905857 PMC: 11467930. DOI: 10.4103/1673-5374.385856.

Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells.

Wang Y, Sharma A, Ge F, Chen P, Yang Y, Liu H Front Oncol. 2023; 13:1157366.

PMID: 37274234 PMC: 10235775. DOI: 10.3389/fonc.2023.1157366.

References

Panegyres P, Chen H . Alzheimer's disease, Huntington's disease and cancer. J Clin Neurosci. 2021; 93:103-105. DOI: 10.1016/j.jocn.2021.09.012. View

Checler F, Alves da Costa C . p53 in neurodegenerative diseases and brain cancers. Pharmacol Ther. 2013; 142(1):99-113. DOI: 10.1016/j.pharmthera.2013.11.009. View

Zhong J, Zhao M, Ma Y, Luo Q, Liu J, Wang J . UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity. Int J Mol Med. 2012; 30(2):430-6. DOI: 10.3892/ijmm.2012.1012. View

Bhattacharya S, Hanpude P, Maiti T . Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation. Sci Rep. 2015; 5:18462. PMC: 4683529. DOI: 10.1038/srep18462. View

Pastorino L, Sun A, Lu P, Zhou X, Balastik M, Finn G . The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature. 2006; 440(7083):528-34. DOI: 10.1038/nature04543. View

Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, Valderas J, Gomez-Beneyto M, Martinez S . Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014; 83(2):89-105. DOI: 10.1159/000356498. View

Chen X, Zhang T, Su W, Dou Z, Zhao D, Jin X . Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis. 2022; 13(11):974. PMC: 9674619. DOI: 10.1038/s41419-022-05408-1. View

Ryo A, Togo T, Nakai T, Hirai A, Nishi M, Yamaguchi A . Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem. 2005; 281(7):4117-25. DOI: 10.1074/jbc.M507026200. View

Chang J, Ghafouri M, Mukerjee R, Bagashev A, Chabrashvili T, Sawaya B . Role of p53 in neurodegenerative diseases. Neurodegener Dis. 2011; 9(2):68-80. PMC: 3304514. DOI: 10.1159/000329999. View

10.

Wang J, Zhang Y, Sun X, Li Y, Li S, Zhang Y . Focusing on the structure and the function of Pin1: new insights into the opposite effects of fever on cancers and Alzheimer's disease. Med Hypotheses. 2013; 81(2):282-4. DOI: 10.1016/j.mehy.2013.04.029. View

11.

Pandini C, Garofalo M, Rey F, Garau J, Zucca S, Sproviero D . MINCR: A long non-coding RNA shared between cancer and neurodegeneration. Genomics. 2021; 113(6):4039-4051. DOI: 10.1016/j.ygeno.2021.10.008. View

12.

Sharma A, Muller J, Schuetze K, Rolfes V, Bissinger R, Rosero N . Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease. Biology (Basel). 2021; 10(8). PMC: 8389253. DOI: 10.3390/biology10080716. View

13.

Ibanez K, Boullosa C, Tabares-Seisdedos R, Baudot A, Valencia A . Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet. 2014; 10(2):e1004173. PMC: 3930576. DOI: 10.1371/journal.pgen.1004173. View

14.

Ye Q, Wen Y, Al-Kuwari N, Chen X . Association Between Parkinson's Disease and Melanoma: Putting the Pieces Together. Front Aging Neurosci. 2020; 12:60. PMC: 7076116. DOI: 10.3389/fnagi.2020.00060. View

15.

Stockwell J, Jakova E, Cayabyab F . Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration. Molecules. 2017; 22(4). PMC: 6154612. DOI: 10.3390/molecules22040676. View

16.

Papin S, Paganetti P . Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer. Brain Sci. 2020; 10(11). PMC: 7696480. DOI: 10.3390/brainsci10110862. View

17.

Fursova N, Turberfield A, Blackledge N, Findlater E, Lastuvkova A, Huseyin M . BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome. Genes Dev. 2021; 35(9-10):749-770. PMC: 8091973. DOI: 10.1101/gad.347005.120. View

18.

Majd S, Power J, Majd Z . Alzheimer's Disease and Cancer: When Two Monsters Cannot Be Together. Front Neurosci. 2019; 13:155. PMC: 6407038. DOI: 10.3389/fnins.2019.00155. View

19.

Lee J, Ng J, Saffari S, Tan E . Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender. Aging (Albany NY). 2022; 14(5):2148-2173. PMC: 8954974. DOI: 10.18632/aging.203932. View

20.

Driver J . Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014; 15(6):547-57. DOI: 10.1007/s10522-014-9523-2. View